Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
19.27
+0.21 (1.08%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $344.47 million as of April 25, 2025. Its market cap has increased by 60.97% in one year.

Market Cap
344.47M
Enterprise Value
367.10M
1-Year Change
60.97%
Ranking
Category
Stock Price
$19.27

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $344.47M, an increase of 35.14%. That is a compound annual growth rate of 1.24%.

History

DateMarket Cap% Change
Apr 25, 2025344.40M16.23%
Dec 31, 2024296.30M17.21%
Dec 29, 2023252.80M-2.51%
Dec 30, 2022259.30M-42.78%
Dec 31, 2021453.20M-23.37%
Dec 31, 2020591.40M64.87%
Dec 31, 2019358.70M-6.42%
Dec 31, 2018383.30M-32.57%
Dec 29, 2017568.40M141.36%
Dec 30, 2016235.50M-12.19%
Dec 31, 2015268.20M34.57%
Dec 31, 2014199.30M-20.02%
Dec 31, 2013249.20M-55.93%
Dec 31, 2012565.50M0.60%
Dec 30, 2011562.10M43.14%
Dec 31, 2010392.70M-20.31%
Dec 31, 2009492.80M68.36%
Dec 31, 2008292.70M-62.86%
Dec 31, 2007788.20M164.67%
Dec 29, 2006297.80M47.43%
Dec 30, 2005202.00M-57.71%
Dec 31, 2004477.70M68.26%
Dec 31, 2003283.90M465.54%
Dec 31, 200250.20M-71.28%
Dec 31, 2001174.80M-51.24%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings